Evaluation of population immunity against SARS-CoV-2 variants, EG.5.1, FY.4, BA.2.86, JN.1, JN.1.4, and KP.3.1.1 using samples from two health demographic surveillance systems in Kenya.

doi:10.1186/s12879-024-10367-3

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Evaluation of population immunity against SARS-CoV-2 variants, EG.5.1, FY.4, BA.2.86, JN.1, JN.1.4, and KP.3.1.1 using samples from two health demographic surveillance systems in Kenya.

BMC infectious diseases - 28 Dec 2024

Lugano Doreen, Kutima Bernadette, Kimani Makobu, Sigilai Antipa, Gitonga John, Karani Angela, Akech Donald, Karia Boniface, Ziraba Abdhalah K, Maina Angela, Lambisia Arnold, Omuoyo Donwilliams, Mugo Daisy, Lucinde Ruth, Owuor Sharon, Konyino Gloria, Newman Joseph, Bailey Dalan, Nduati Eunice, Githinji George, Agoti Charles N, Bejon Philip, Scott J Anthony G, Agweyu Ambrose, Kagucia Wangeci, Warimwe George M, Sande Charles, Ochola-Oyier Lynette I, Nyagwange James

Abstract excerpt

Increased immune evasion by emerging and highly mutated SARS-CoV-2 variants is a key challenge to the control of COVID-19. The majority of these mutations mainly target the spike protein, allowing the new variants to escape the immunity previously raised by vaccination and/or infection by earlier variants of SARS-CoV-2. In this study, we investigated the neutralizing capacity of antibodies against emerging...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Antibodies, Neutralizing

Share to Antibodies, Viral

Share to COVID-19

Share to Kenya

Share to SARS-CoV-2

Share to Spike Glycoprotein, Coronavirus

Share to Young Adult

Source

Open in PubMed Open full text

Identifiers

PMID: 39732637
DOI: 10.1186/s12879-024-10367-3
PMCID: PMC11682625

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 9 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of population immunity against SARS-CoV-2 variants, EG.5.1, FY.4, BA.2.86, JN.1, JN.1.4, and KP.3.1.1 using samples from two health demographic surveillance systems in Kenya.PMID 39732637Read ↗

Anti-inflammatory SARS-CoV-2 T cell immunity in asymptomatic seronegative Kenyan adultsSemantic proximity Read ↗

Characterization of SARS-CoV-2 genetic evolution in vaccinated and non-vaccinated patients from the Kenyan populationSemantic proximity Read ↗

Kinetics of naturally induced binding and neutralising anti-SARS-CoV-2 antibody levels and potencies among SARS-CoV-2 infected Kenyans with diverse grades of COVID-19 severity: an observational studySemantic proximity Read ↗

Assessment of neutralizing antibody responses after natural SARS-CoV-2 infection and vaccination in Congolese individualsSemantic proximity Read ↗

Characterization of SARS-CoV-2 intrahost genetic evolution in vaccinated and non-vaccinated patients from the Kenyan populationSemantic proximity Read ↗

Changes in population immunity to omicron SARS-CoV-2 variants and selected Sarbecoviruses from 2020 to 2023 in urban Colombo, Sri LankaSemantic proximity Read ↗

Kinetics of naturally induced binding and neutralizing anti-SARS-CoV-2 antibody levels and potencies among Kenyan patients with diverse grades of COVID-19 severitySemantic proximity Read ↗

Changes in population immunity against infection and severe disease from SARS-CoV-2 Omicron variants in the United States between December 2021 and November 2022Semantic proximity Read ↗

Emerging Mutations of SARS-COV-2 in KenyaSemantic proximity Read ↗

Immune imprinting and antibody profiles to SARS-CoV-2 in urban and rural GhanaSemantic proximity Read ↗

Population immunity to pre-Omicron and Omicron SARS-CoV-2 variants in US states and counties through December 1, 2021Semantic proximity Read ↗

Determinants of long-term SARS-CoV-2 immune responses in asymptomatic-to- moderate COVID-19 patients in sub-Saharan AfricaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.